Global Tissue and Organ Transplantation Supply, Demand and Key Producers, 2024-2030

Global Tissue and Organ Transplantation Supply, Demand and Key Producers, 2024-2030

Page: 119

Published Date: 29 Feb 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global Tissue and Organ Transplantation market size is expected to reach $ 24660 million by 2030, rising at a market growth of 8.1% CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Chronic diseases often lead to catastrophic damage to vital organs. This damage is usually irreversible and leads to lifetime dependency on medicines. Under such severe conditions, transplants remain the component for restoration of healthy life.

This report studies the global Tissue and Organ Transplantation demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Tissue and Organ Transplantation, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Tissue and Organ Transplantation that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Tissue and Organ Transplantation total market, 2019-2030, (USD Million)
Global Tissue and Organ Transplantation total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Tissue and Organ Transplantation total market, key domestic companies and share, (USD Million)
Global Tissue and Organ Transplantation revenue by player and market share 2019-2024, (USD Million)
Global Tissue and Organ Transplantation total market by Type, CAGR, 2019-2030, (USD Million)
Global Tissue and Organ Transplantation total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Tissue and Organ Transplantation market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Discovery Life Sciences, Arthrex, Abbvie, Zimmer Biomet, Medtronic, Novartis, Stryker Corporation, Biolife Solutions and Teva Pharmaceuticals, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Tissue and Organ Transplantation market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Tissue and Organ Transplantation Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Tissue and Organ Transplantation Market, Segmentation by Type
Tissue Products
Preservation Solution
Immunosuppressive Drugs

Global Tissue and Organ Transplantation Market, Segmentation by Application
Hospital
Transplant Centers
Others

Companies Profiled:
Discovery Life Sciences
Arthrex
Abbvie
Zimmer Biomet
Medtronic
Novartis
Stryker Corporation
Biolife Solutions
Teva Pharmaceuticals
Veloxis Pharmaceutical

Key Questions Answered
1. How big is the global Tissue and Organ Transplantation market?
2. What is the demand of the global Tissue and Organ Transplantation market?
3. What is the year over year growth of the global Tissue and Organ Transplantation market?
4. What is the total value of the global Tissue and Organ Transplantation market?
5. Who are the major players in the global Tissue and Organ Transplantation market?
btl

Table of Contents

1 Supply Summary
1.1 Tissue and Organ Transplantation Introduction
1.2 World Tissue and Organ Transplantation Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Tissue and Organ Transplantation Total Market by Region (by Headquarter Location)
1.3.1 World Tissue and Organ Transplantation Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Tissue and Organ Transplantation Market Size (2019-2030)
1.3.3 China Tissue and Organ Transplantation Market Size (2019-2030)
1.3.4 Europe Tissue and Organ Transplantation Market Size (2019-2030)
1.3.5 Japan Tissue and Organ Transplantation Market Size (2019-2030)
1.3.6 South Korea Tissue and Organ Transplantation Market Size (2019-2030)
1.3.7 ASEAN Tissue and Organ Transplantation Market Size (2019-2030)
1.3.8 India Tissue and Organ Transplantation Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Tissue and Organ Transplantation Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Tissue and Organ Transplantation Major Market Trends

2 Demand Summary
2.1 World Tissue and Organ Transplantation Consumption Value (2019-2030)
2.2 World Tissue and Organ Transplantation Consumption Value by Region
2.2.1 World Tissue and Organ Transplantation Consumption Value by Region (2019-2024)
2.2.2 World Tissue and Organ Transplantation Consumption Value Forecast by Region (2025-2030)
2.3 United States Tissue and Organ Transplantation Consumption Value (2019-2030)
2.4 China Tissue and Organ Transplantation Consumption Value (2019-2030)
2.5 Europe Tissue and Organ Transplantation Consumption Value (2019-2030)
2.6 Japan Tissue and Organ Transplantation Consumption Value (2019-2030)
2.7 South Korea Tissue and Organ Transplantation Consumption Value (2019-2030)
2.8 ASEAN Tissue and Organ Transplantation Consumption Value (2019-2030)
2.9 India Tissue and Organ Transplantation Consumption Value (2019-2030)

3 World Tissue and Organ Transplantation Companies Competitive Analysis
3.1 World Tissue and Organ Transplantation Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Tissue and Organ Transplantation Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Tissue and Organ Transplantation in 2023
3.2.3 Global Concentration Ratios (CR8) for Tissue and Organ Transplantation in 2023
3.3 Tissue and Organ Transplantation Company Evaluation Quadrant
3.4 Tissue and Organ Transplantation Market: Overall Company Footprint Analysis
3.4.1 Tissue and Organ Transplantation Market: Region Footprint
3.4.2 Tissue and Organ Transplantation Market: Company Product Type Footprint
3.4.3 Tissue and Organ Transplantation Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: Tissue and Organ Transplantation Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Tissue and Organ Transplantation Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Tissue and Organ Transplantation Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Tissue and Organ Transplantation Consumption Value Comparison
4.2.1 United States VS China: Tissue and Organ Transplantation Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Tissue and Organ Transplantation Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Tissue and Organ Transplantation Companies and Market Share, 2019-2024
4.3.1 United States Based Tissue and Organ Transplantation Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Tissue and Organ Transplantation Revenue, (2019-2024)
4.4 China Based Companies Tissue and Organ Transplantation Revenue and Market Share, 2019-2024
4.4.1 China Based Tissue and Organ Transplantation Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Tissue and Organ Transplantation Revenue, (2019-2024)
4.5 Rest of World Based Tissue and Organ Transplantation Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Tissue and Organ Transplantation Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Tissue and Organ Transplantation Revenue, (2019-2024)

5 Market Analysis by Type
5.1 World Tissue and Organ Transplantation Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Tissue Products
5.2.2 Preservation Solution
5.2.3 Immunosuppressive Drugs
5.3 Market Segment by Type
5.3.1 World Tissue and Organ Transplantation Market Size by Type (2019-2024)
5.3.2 World Tissue and Organ Transplantation Market Size by Type (2025-2030)
5.3.3 World Tissue and Organ Transplantation Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
6.1 World Tissue and Organ Transplantation Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Transplant Centers
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Tissue and Organ Transplantation Market Size by Application (2019-2024)
6.3.2 World Tissue and Organ Transplantation Market Size by Application (2025-2030)
6.3.3 World Tissue and Organ Transplantation Market Size by Application (2019-2030)

7 Company Profiles
7.1 Discovery Life Sciences
7.1.1 Discovery Life Sciences Details
7.1.2 Discovery Life Sciences Major Business
7.1.3 Discovery Life Sciences Tissue and Organ Transplantation Product and Services
7.1.4 Discovery Life Sciences Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Discovery Life Sciences Recent Developments/Updates
7.1.6 Discovery Life Sciences Competitive Strengths & Weaknesses
7.2 Arthrex
7.2.1 Arthrex Details
7.2.2 Arthrex Major Business
7.2.3 Arthrex Tissue and Organ Transplantation Product and Services
7.2.4 Arthrex Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Arthrex Recent Developments/Updates
7.2.6 Arthrex Competitive Strengths & Weaknesses
7.3 Abbvie
7.3.1 Abbvie Details
7.3.2 Abbvie Major Business
7.3.3 Abbvie Tissue and Organ Transplantation Product and Services
7.3.4 Abbvie Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Abbvie Recent Developments/Updates
7.3.6 Abbvie Competitive Strengths & Weaknesses
7.4 Zimmer Biomet
7.4.1 Zimmer Biomet Details
7.4.2 Zimmer Biomet Major Business
7.4.3 Zimmer Biomet Tissue and Organ Transplantation Product and Services
7.4.4 Zimmer Biomet Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 Zimmer Biomet Recent Developments/Updates
7.4.6 Zimmer Biomet Competitive Strengths & Weaknesses
7.5 Medtronic
7.5.1 Medtronic Details
7.5.2 Medtronic Major Business
7.5.3 Medtronic Tissue and Organ Transplantation Product and Services
7.5.4 Medtronic Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Medtronic Recent Developments/Updates
7.5.6 Medtronic Competitive Strengths & Weaknesses
7.6 Novartis
7.6.1 Novartis Details
7.6.2 Novartis Major Business
7.6.3 Novartis Tissue and Organ Transplantation Product and Services
7.6.4 Novartis Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Novartis Recent Developments/Updates
7.6.6 Novartis Competitive Strengths & Weaknesses
7.7 Stryker Corporation
7.7.1 Stryker Corporation Details
7.7.2 Stryker Corporation Major Business
7.7.3 Stryker Corporation Tissue and Organ Transplantation Product and Services
7.7.4 Stryker Corporation Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Stryker Corporation Recent Developments/Updates
7.7.6 Stryker Corporation Competitive Strengths & Weaknesses
7.8 Biolife Solutions
7.8.1 Biolife Solutions Details
7.8.2 Biolife Solutions Major Business
7.8.3 Biolife Solutions Tissue and Organ Transplantation Product and Services
7.8.4 Biolife Solutions Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Biolife Solutions Recent Developments/Updates
7.8.6 Biolife Solutions Competitive Strengths & Weaknesses
7.9 Teva Pharmaceuticals
7.9.1 Teva Pharmaceuticals Details
7.9.2 Teva Pharmaceuticals Major Business
7.9.3 Teva Pharmaceuticals Tissue and Organ Transplantation Product and Services
7.9.4 Teva Pharmaceuticals Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Teva Pharmaceuticals Recent Developments/Updates
7.9.6 Teva Pharmaceuticals Competitive Strengths & Weaknesses
7.10 Veloxis Pharmaceutical
7.10.1 Veloxis Pharmaceutical Details
7.10.2 Veloxis Pharmaceutical Major Business
7.10.3 Veloxis Pharmaceutical Tissue and Organ Transplantation Product and Services
7.10.4 Veloxis Pharmaceutical Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 Veloxis Pharmaceutical Recent Developments/Updates
7.10.6 Veloxis Pharmaceutical Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Tissue and Organ Transplantation Industry Chain
8.2 Tissue and Organ Transplantation Upstream Analysis
8.3 Tissue and Organ Transplantation Midstream Analysis
8.4 Tissue and Organ Transplantation Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Tissue and Organ Transplantation Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Tissue and Organ Transplantation Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Tissue and Organ Transplantation Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Tissue and Organ Transplantation Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Tissue and Organ Transplantation Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Tissue and Organ Transplantation Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Tissue and Organ Transplantation Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Tissue and Organ Transplantation Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Tissue and Organ Transplantation Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Tissue and Organ Transplantation Players in 2023
Table 12. World Tissue and Organ Transplantation Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Tissue and Organ Transplantation Company Evaluation Quadrant
Table 14. Head Office of Key Tissue and Organ Transplantation Player
Table 15. Tissue and Organ Transplantation Market: Company Product Type Footprint
Table 16. Tissue and Organ Transplantation Market: Company Product Application Footprint
Table 17. Tissue and Organ Transplantation Mergers & Acquisitions Activity
Table 18. United States VS China Tissue and Organ Transplantation Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Tissue and Organ Transplantation Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Tissue and Organ Transplantation Companies, Headquarters (States, Country)
Table 21. United States Based Companies Tissue and Organ Transplantation Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Tissue and Organ Transplantation Revenue Market Share (2019-2024)
Table 23. China Based Tissue and Organ Transplantation Companies, Headquarters (Province, Country)
Table 24. China Based Companies Tissue and Organ Transplantation Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Tissue and Organ Transplantation Revenue Market Share (2019-2024)
Table 26. Rest of World Based Tissue and Organ Transplantation Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Tissue and Organ Transplantation Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Tissue and Organ Transplantation Revenue Market Share (2019-2024)
Table 29. World Tissue and Organ Transplantation Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Tissue and Organ Transplantation Market Size by Type (2019-2024) & (USD Million)
Table 31. World Tissue and Organ Transplantation Market Size by Type (2025-2030) & (USD Million)
Table 32. World Tissue and Organ Transplantation Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Tissue and Organ Transplantation Market Size by Application (2019-2024) & (USD Million)
Table 34. World Tissue and Organ Transplantation Market Size by Application (2025-2030) & (USD Million)
Table 35. Discovery Life Sciences Basic Information, Area Served and Competitors
Table 36. Discovery Life Sciences Major Business
Table 37. Discovery Life Sciences Tissue and Organ Transplantation Product and Services
Table 38. Discovery Life Sciences Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Discovery Life Sciences Recent Developments/Updates
Table 40. Discovery Life Sciences Competitive Strengths & Weaknesses
Table 41. Arthrex Basic Information, Area Served and Competitors
Table 42. Arthrex Major Business
Table 43. Arthrex Tissue and Organ Transplantation Product and Services
Table 44. Arthrex Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Arthrex Recent Developments/Updates
Table 46. Arthrex Competitive Strengths & Weaknesses
Table 47. Abbvie Basic Information, Area Served and Competitors
Table 48. Abbvie Major Business
Table 49. Abbvie Tissue and Organ Transplantation Product and Services
Table 50. Abbvie Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Abbvie Recent Developments/Updates
Table 52. Abbvie Competitive Strengths & Weaknesses
Table 53. Zimmer Biomet Basic Information, Area Served and Competitors
Table 54. Zimmer Biomet Major Business
Table 55. Zimmer Biomet Tissue and Organ Transplantation Product and Services
Table 56. Zimmer Biomet Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. Zimmer Biomet Recent Developments/Updates
Table 58. Zimmer Biomet Competitive Strengths & Weaknesses
Table 59. Medtronic Basic Information, Area Served and Competitors
Table 60. Medtronic Major Business
Table 61. Medtronic Tissue and Organ Transplantation Product and Services
Table 62. Medtronic Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Medtronic Recent Developments/Updates
Table 64. Medtronic Competitive Strengths & Weaknesses
Table 65. Novartis Basic Information, Area Served and Competitors
Table 66. Novartis Major Business
Table 67. Novartis Tissue and Organ Transplantation Product and Services
Table 68. Novartis Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Novartis Recent Developments/Updates
Table 70. Novartis Competitive Strengths & Weaknesses
Table 71. Stryker Corporation Basic Information, Area Served and Competitors
Table 72. Stryker Corporation Major Business
Table 73. Stryker Corporation Tissue and Organ Transplantation Product and Services
Table 74. Stryker Corporation Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Stryker Corporation Recent Developments/Updates
Table 76. Stryker Corporation Competitive Strengths & Weaknesses
Table 77. Biolife Solutions Basic Information, Area Served and Competitors
Table 78. Biolife Solutions Major Business
Table 79. Biolife Solutions Tissue and Organ Transplantation Product and Services
Table 80. Biolife Solutions Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Biolife Solutions Recent Developments/Updates
Table 82. Biolife Solutions Competitive Strengths & Weaknesses
Table 83. Teva Pharmaceuticals Basic Information, Area Served and Competitors
Table 84. Teva Pharmaceuticals Major Business
Table 85. Teva Pharmaceuticals Tissue and Organ Transplantation Product and Services
Table 86. Teva Pharmaceuticals Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. Teva Pharmaceuticals Recent Developments/Updates
Table 88. Veloxis Pharmaceutical Basic Information, Area Served and Competitors
Table 89. Veloxis Pharmaceutical Major Business
Table 90. Veloxis Pharmaceutical Tissue and Organ Transplantation Product and Services
Table 91. Veloxis Pharmaceutical Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 92. Global Key Players of Tissue and Organ Transplantation Upstream (Raw Materials)
Table 93. Tissue and Organ Transplantation Typical Customers
List of Figure
Figure 1. Tissue and Organ Transplantation Picture
Figure 2. World Tissue and Organ Transplantation Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Tissue and Organ Transplantation Total Market Size (2019-2030) & (USD Million)
Figure 4. World Tissue and Organ Transplantation Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World Tissue and Organ Transplantation Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Tissue and Organ Transplantation Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Tissue and Organ Transplantation Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Tissue and Organ Transplantation Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Tissue and Organ Transplantation Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Tissue and Organ Transplantation Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Tissue and Organ Transplantation Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Tissue and Organ Transplantation Revenue (2019-2030) & (USD Million)
Figure 13. Tissue and Organ Transplantation Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Tissue and Organ Transplantation Consumption Value (2019-2030) & (USD Million)
Figure 16. World Tissue and Organ Transplantation Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Tissue and Organ Transplantation Consumption Value (2019-2030) & (USD Million)
Figure 18. China Tissue and Organ Transplantation Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Tissue and Organ Transplantation Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Tissue and Organ Transplantation Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Tissue and Organ Transplantation Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Tissue and Organ Transplantation Consumption Value (2019-2030) & (USD Million)
Figure 23. India Tissue and Organ Transplantation Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Tissue and Organ Transplantation by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Tissue and Organ Transplantation Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Tissue and Organ Transplantation Markets in 2023
Figure 27. United States VS China: Tissue and Organ Transplantation Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Tissue and Organ Transplantation Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Tissue and Organ Transplantation Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Tissue and Organ Transplantation Market Size Market Share by Type in 2023
Figure 31. Tissue Products
Figure 32. Preservation Solution
Figure 33. Immunosuppressive Drugs
Figure 34. World Tissue and Organ Transplantation Market Size Market Share by Type (2019-2030)
Figure 35. World Tissue and Organ Transplantation Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 36. World Tissue and Organ Transplantation Market Size Market Share by Application in 2023
Figure 37. Hospital
Figure 38. Transplant Centers
Figure 39. Others
Figure 40. Tissue and Organ Transplantation Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Discovery Life Sciences
Arthrex
Abbvie
Zimmer Biomet
Medtronic
Novartis
Stryker Corporation
Biolife Solutions
Teva Pharmaceuticals
Veloxis Pharmaceutical
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Tissue and Organ Transplantation Supply, Demand and Key Producers, 2024-2030

Global Tissue and Organ Transplantation Supply, Demand and Key Producers, 2024-2030

Page: 119

Published Date: 29 Feb 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global Tissue and Organ Transplantation market size is expected to reach $ 24660 million by 2030, rising at a market growth of 8.1% CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Chronic diseases often lead to catastrophic damage to vital organs. This damage is usually irreversible and leads to lifetime dependency on medicines. Under such severe conditions, transplants remain the component for restoration of healthy life.

This report studies the global Tissue and Organ Transplantation demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Tissue and Organ Transplantation, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Tissue and Organ Transplantation that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Tissue and Organ Transplantation total market, 2019-2030, (USD Million)
Global Tissue and Organ Transplantation total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Tissue and Organ Transplantation total market, key domestic companies and share, (USD Million)
Global Tissue and Organ Transplantation revenue by player and market share 2019-2024, (USD Million)
Global Tissue and Organ Transplantation total market by Type, CAGR, 2019-2030, (USD Million)
Global Tissue and Organ Transplantation total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Tissue and Organ Transplantation market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Discovery Life Sciences, Arthrex, Abbvie, Zimmer Biomet, Medtronic, Novartis, Stryker Corporation, Biolife Solutions and Teva Pharmaceuticals, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Tissue and Organ Transplantation market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Tissue and Organ Transplantation Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Tissue and Organ Transplantation Market, Segmentation by Type
Tissue Products
Preservation Solution
Immunosuppressive Drugs

Global Tissue and Organ Transplantation Market, Segmentation by Application
Hospital
Transplant Centers
Others

Companies Profiled:
Discovery Life Sciences
Arthrex
Abbvie
Zimmer Biomet
Medtronic
Novartis
Stryker Corporation
Biolife Solutions
Teva Pharmaceuticals
Veloxis Pharmaceutical

Key Questions Answered
1. How big is the global Tissue and Organ Transplantation market?
2. What is the demand of the global Tissue and Organ Transplantation market?
3. What is the year over year growth of the global Tissue and Organ Transplantation market?
4. What is the total value of the global Tissue and Organ Transplantation market?
5. Who are the major players in the global Tissue and Organ Transplantation market?
btl

Table of Contents

1 Supply Summary
1.1 Tissue and Organ Transplantation Introduction
1.2 World Tissue and Organ Transplantation Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Tissue and Organ Transplantation Total Market by Region (by Headquarter Location)
1.3.1 World Tissue and Organ Transplantation Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Tissue and Organ Transplantation Market Size (2019-2030)
1.3.3 China Tissue and Organ Transplantation Market Size (2019-2030)
1.3.4 Europe Tissue and Organ Transplantation Market Size (2019-2030)
1.3.5 Japan Tissue and Organ Transplantation Market Size (2019-2030)
1.3.6 South Korea Tissue and Organ Transplantation Market Size (2019-2030)
1.3.7 ASEAN Tissue and Organ Transplantation Market Size (2019-2030)
1.3.8 India Tissue and Organ Transplantation Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Tissue and Organ Transplantation Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Tissue and Organ Transplantation Major Market Trends

2 Demand Summary
2.1 World Tissue and Organ Transplantation Consumption Value (2019-2030)
2.2 World Tissue and Organ Transplantation Consumption Value by Region
2.2.1 World Tissue and Organ Transplantation Consumption Value by Region (2019-2024)
2.2.2 World Tissue and Organ Transplantation Consumption Value Forecast by Region (2025-2030)
2.3 United States Tissue and Organ Transplantation Consumption Value (2019-2030)
2.4 China Tissue and Organ Transplantation Consumption Value (2019-2030)
2.5 Europe Tissue and Organ Transplantation Consumption Value (2019-2030)
2.6 Japan Tissue and Organ Transplantation Consumption Value (2019-2030)
2.7 South Korea Tissue and Organ Transplantation Consumption Value (2019-2030)
2.8 ASEAN Tissue and Organ Transplantation Consumption Value (2019-2030)
2.9 India Tissue and Organ Transplantation Consumption Value (2019-2030)

3 World Tissue and Organ Transplantation Companies Competitive Analysis
3.1 World Tissue and Organ Transplantation Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Tissue and Organ Transplantation Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Tissue and Organ Transplantation in 2023
3.2.3 Global Concentration Ratios (CR8) for Tissue and Organ Transplantation in 2023
3.3 Tissue and Organ Transplantation Company Evaluation Quadrant
3.4 Tissue and Organ Transplantation Market: Overall Company Footprint Analysis
3.4.1 Tissue and Organ Transplantation Market: Region Footprint
3.4.2 Tissue and Organ Transplantation Market: Company Product Type Footprint
3.4.3 Tissue and Organ Transplantation Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: Tissue and Organ Transplantation Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Tissue and Organ Transplantation Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Tissue and Organ Transplantation Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Tissue and Organ Transplantation Consumption Value Comparison
4.2.1 United States VS China: Tissue and Organ Transplantation Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Tissue and Organ Transplantation Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Tissue and Organ Transplantation Companies and Market Share, 2019-2024
4.3.1 United States Based Tissue and Organ Transplantation Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Tissue and Organ Transplantation Revenue, (2019-2024)
4.4 China Based Companies Tissue and Organ Transplantation Revenue and Market Share, 2019-2024
4.4.1 China Based Tissue and Organ Transplantation Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Tissue and Organ Transplantation Revenue, (2019-2024)
4.5 Rest of World Based Tissue and Organ Transplantation Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Tissue and Organ Transplantation Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Tissue and Organ Transplantation Revenue, (2019-2024)

5 Market Analysis by Type
5.1 World Tissue and Organ Transplantation Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Tissue Products
5.2.2 Preservation Solution
5.2.3 Immunosuppressive Drugs
5.3 Market Segment by Type
5.3.1 World Tissue and Organ Transplantation Market Size by Type (2019-2024)
5.3.2 World Tissue and Organ Transplantation Market Size by Type (2025-2030)
5.3.3 World Tissue and Organ Transplantation Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
6.1 World Tissue and Organ Transplantation Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Transplant Centers
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Tissue and Organ Transplantation Market Size by Application (2019-2024)
6.3.2 World Tissue and Organ Transplantation Market Size by Application (2025-2030)
6.3.3 World Tissue and Organ Transplantation Market Size by Application (2019-2030)

7 Company Profiles
7.1 Discovery Life Sciences
7.1.1 Discovery Life Sciences Details
7.1.2 Discovery Life Sciences Major Business
7.1.3 Discovery Life Sciences Tissue and Organ Transplantation Product and Services
7.1.4 Discovery Life Sciences Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Discovery Life Sciences Recent Developments/Updates
7.1.6 Discovery Life Sciences Competitive Strengths & Weaknesses
7.2 Arthrex
7.2.1 Arthrex Details
7.2.2 Arthrex Major Business
7.2.3 Arthrex Tissue and Organ Transplantation Product and Services
7.2.4 Arthrex Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Arthrex Recent Developments/Updates
7.2.6 Arthrex Competitive Strengths & Weaknesses
7.3 Abbvie
7.3.1 Abbvie Details
7.3.2 Abbvie Major Business
7.3.3 Abbvie Tissue and Organ Transplantation Product and Services
7.3.4 Abbvie Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Abbvie Recent Developments/Updates
7.3.6 Abbvie Competitive Strengths & Weaknesses
7.4 Zimmer Biomet
7.4.1 Zimmer Biomet Details
7.4.2 Zimmer Biomet Major Business
7.4.3 Zimmer Biomet Tissue and Organ Transplantation Product and Services
7.4.4 Zimmer Biomet Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 Zimmer Biomet Recent Developments/Updates
7.4.6 Zimmer Biomet Competitive Strengths & Weaknesses
7.5 Medtronic
7.5.1 Medtronic Details
7.5.2 Medtronic Major Business
7.5.3 Medtronic Tissue and Organ Transplantation Product and Services
7.5.4 Medtronic Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Medtronic Recent Developments/Updates
7.5.6 Medtronic Competitive Strengths & Weaknesses
7.6 Novartis
7.6.1 Novartis Details
7.6.2 Novartis Major Business
7.6.3 Novartis Tissue and Organ Transplantation Product and Services
7.6.4 Novartis Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Novartis Recent Developments/Updates
7.6.6 Novartis Competitive Strengths & Weaknesses
7.7 Stryker Corporation
7.7.1 Stryker Corporation Details
7.7.2 Stryker Corporation Major Business
7.7.3 Stryker Corporation Tissue and Organ Transplantation Product and Services
7.7.4 Stryker Corporation Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Stryker Corporation Recent Developments/Updates
7.7.6 Stryker Corporation Competitive Strengths & Weaknesses
7.8 Biolife Solutions
7.8.1 Biolife Solutions Details
7.8.2 Biolife Solutions Major Business
7.8.3 Biolife Solutions Tissue and Organ Transplantation Product and Services
7.8.4 Biolife Solutions Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Biolife Solutions Recent Developments/Updates
7.8.6 Biolife Solutions Competitive Strengths & Weaknesses
7.9 Teva Pharmaceuticals
7.9.1 Teva Pharmaceuticals Details
7.9.2 Teva Pharmaceuticals Major Business
7.9.3 Teva Pharmaceuticals Tissue and Organ Transplantation Product and Services
7.9.4 Teva Pharmaceuticals Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Teva Pharmaceuticals Recent Developments/Updates
7.9.6 Teva Pharmaceuticals Competitive Strengths & Weaknesses
7.10 Veloxis Pharmaceutical
7.10.1 Veloxis Pharmaceutical Details
7.10.2 Veloxis Pharmaceutical Major Business
7.10.3 Veloxis Pharmaceutical Tissue and Organ Transplantation Product and Services
7.10.4 Veloxis Pharmaceutical Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 Veloxis Pharmaceutical Recent Developments/Updates
7.10.6 Veloxis Pharmaceutical Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Tissue and Organ Transplantation Industry Chain
8.2 Tissue and Organ Transplantation Upstream Analysis
8.3 Tissue and Organ Transplantation Midstream Analysis
8.4 Tissue and Organ Transplantation Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Tissue and Organ Transplantation Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Tissue and Organ Transplantation Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Tissue and Organ Transplantation Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Tissue and Organ Transplantation Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Tissue and Organ Transplantation Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Tissue and Organ Transplantation Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Tissue and Organ Transplantation Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Tissue and Organ Transplantation Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Tissue and Organ Transplantation Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Tissue and Organ Transplantation Players in 2023
Table 12. World Tissue and Organ Transplantation Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Tissue and Organ Transplantation Company Evaluation Quadrant
Table 14. Head Office of Key Tissue and Organ Transplantation Player
Table 15. Tissue and Organ Transplantation Market: Company Product Type Footprint
Table 16. Tissue and Organ Transplantation Market: Company Product Application Footprint
Table 17. Tissue and Organ Transplantation Mergers & Acquisitions Activity
Table 18. United States VS China Tissue and Organ Transplantation Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Tissue and Organ Transplantation Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Tissue and Organ Transplantation Companies, Headquarters (States, Country)
Table 21. United States Based Companies Tissue and Organ Transplantation Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Tissue and Organ Transplantation Revenue Market Share (2019-2024)
Table 23. China Based Tissue and Organ Transplantation Companies, Headquarters (Province, Country)
Table 24. China Based Companies Tissue and Organ Transplantation Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Tissue and Organ Transplantation Revenue Market Share (2019-2024)
Table 26. Rest of World Based Tissue and Organ Transplantation Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Tissue and Organ Transplantation Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Tissue and Organ Transplantation Revenue Market Share (2019-2024)
Table 29. World Tissue and Organ Transplantation Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Tissue and Organ Transplantation Market Size by Type (2019-2024) & (USD Million)
Table 31. World Tissue and Organ Transplantation Market Size by Type (2025-2030) & (USD Million)
Table 32. World Tissue and Organ Transplantation Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Tissue and Organ Transplantation Market Size by Application (2019-2024) & (USD Million)
Table 34. World Tissue and Organ Transplantation Market Size by Application (2025-2030) & (USD Million)
Table 35. Discovery Life Sciences Basic Information, Area Served and Competitors
Table 36. Discovery Life Sciences Major Business
Table 37. Discovery Life Sciences Tissue and Organ Transplantation Product and Services
Table 38. Discovery Life Sciences Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Discovery Life Sciences Recent Developments/Updates
Table 40. Discovery Life Sciences Competitive Strengths & Weaknesses
Table 41. Arthrex Basic Information, Area Served and Competitors
Table 42. Arthrex Major Business
Table 43. Arthrex Tissue and Organ Transplantation Product and Services
Table 44. Arthrex Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Arthrex Recent Developments/Updates
Table 46. Arthrex Competitive Strengths & Weaknesses
Table 47. Abbvie Basic Information, Area Served and Competitors
Table 48. Abbvie Major Business
Table 49. Abbvie Tissue and Organ Transplantation Product and Services
Table 50. Abbvie Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Abbvie Recent Developments/Updates
Table 52. Abbvie Competitive Strengths & Weaknesses
Table 53. Zimmer Biomet Basic Information, Area Served and Competitors
Table 54. Zimmer Biomet Major Business
Table 55. Zimmer Biomet Tissue and Organ Transplantation Product and Services
Table 56. Zimmer Biomet Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. Zimmer Biomet Recent Developments/Updates
Table 58. Zimmer Biomet Competitive Strengths & Weaknesses
Table 59. Medtronic Basic Information, Area Served and Competitors
Table 60. Medtronic Major Business
Table 61. Medtronic Tissue and Organ Transplantation Product and Services
Table 62. Medtronic Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Medtronic Recent Developments/Updates
Table 64. Medtronic Competitive Strengths & Weaknesses
Table 65. Novartis Basic Information, Area Served and Competitors
Table 66. Novartis Major Business
Table 67. Novartis Tissue and Organ Transplantation Product and Services
Table 68. Novartis Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Novartis Recent Developments/Updates
Table 70. Novartis Competitive Strengths & Weaknesses
Table 71. Stryker Corporation Basic Information, Area Served and Competitors
Table 72. Stryker Corporation Major Business
Table 73. Stryker Corporation Tissue and Organ Transplantation Product and Services
Table 74. Stryker Corporation Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Stryker Corporation Recent Developments/Updates
Table 76. Stryker Corporation Competitive Strengths & Weaknesses
Table 77. Biolife Solutions Basic Information, Area Served and Competitors
Table 78. Biolife Solutions Major Business
Table 79. Biolife Solutions Tissue and Organ Transplantation Product and Services
Table 80. Biolife Solutions Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Biolife Solutions Recent Developments/Updates
Table 82. Biolife Solutions Competitive Strengths & Weaknesses
Table 83. Teva Pharmaceuticals Basic Information, Area Served and Competitors
Table 84. Teva Pharmaceuticals Major Business
Table 85. Teva Pharmaceuticals Tissue and Organ Transplantation Product and Services
Table 86. Teva Pharmaceuticals Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. Teva Pharmaceuticals Recent Developments/Updates
Table 88. Veloxis Pharmaceutical Basic Information, Area Served and Competitors
Table 89. Veloxis Pharmaceutical Major Business
Table 90. Veloxis Pharmaceutical Tissue and Organ Transplantation Product and Services
Table 91. Veloxis Pharmaceutical Tissue and Organ Transplantation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 92. Global Key Players of Tissue and Organ Transplantation Upstream (Raw Materials)
Table 93. Tissue and Organ Transplantation Typical Customers
List of Figure
Figure 1. Tissue and Organ Transplantation Picture
Figure 2. World Tissue and Organ Transplantation Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Tissue and Organ Transplantation Total Market Size (2019-2030) & (USD Million)
Figure 4. World Tissue and Organ Transplantation Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World Tissue and Organ Transplantation Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Tissue and Organ Transplantation Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Tissue and Organ Transplantation Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Tissue and Organ Transplantation Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Tissue and Organ Transplantation Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Tissue and Organ Transplantation Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Tissue and Organ Transplantation Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Tissue and Organ Transplantation Revenue (2019-2030) & (USD Million)
Figure 13. Tissue and Organ Transplantation Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Tissue and Organ Transplantation Consumption Value (2019-2030) & (USD Million)
Figure 16. World Tissue and Organ Transplantation Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Tissue and Organ Transplantation Consumption Value (2019-2030) & (USD Million)
Figure 18. China Tissue and Organ Transplantation Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Tissue and Organ Transplantation Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Tissue and Organ Transplantation Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Tissue and Organ Transplantation Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Tissue and Organ Transplantation Consumption Value (2019-2030) & (USD Million)
Figure 23. India Tissue and Organ Transplantation Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Tissue and Organ Transplantation by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Tissue and Organ Transplantation Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Tissue and Organ Transplantation Markets in 2023
Figure 27. United States VS China: Tissue and Organ Transplantation Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Tissue and Organ Transplantation Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Tissue and Organ Transplantation Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Tissue and Organ Transplantation Market Size Market Share by Type in 2023
Figure 31. Tissue Products
Figure 32. Preservation Solution
Figure 33. Immunosuppressive Drugs
Figure 34. World Tissue and Organ Transplantation Market Size Market Share by Type (2019-2030)
Figure 35. World Tissue and Organ Transplantation Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 36. World Tissue and Organ Transplantation Market Size Market Share by Application in 2023
Figure 37. Hospital
Figure 38. Transplant Centers
Figure 39. Others
Figure 40. Tissue and Organ Transplantation Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Discovery Life Sciences
Arthrex
Abbvie
Zimmer Biomet
Medtronic
Novartis
Stryker Corporation
Biolife Solutions
Teva Pharmaceuticals
Veloxis Pharmaceutical
jiaGou

Add To Cart

gouMai

Buy Now